Roche's Genentech, Nvidia Team Up to Accelerate Drug Discovery With AI
November 21 2023 - 11:06AM
Dow Jones News
By Nina Kienle
Roche Holding's Genentech and U.S. chip giant Nvidia have
entered into a multiyear artificial-intelligence research
collaboration to accelerate drug discovery and development.
California-based biotechnology company Genentech said Tuesday
that the collaboration aims to combine its AI capabilities with
Nvidia's computing expertise. It specifically looks to create a
next-generation AI platform and, through that, improve or enhance
Nvidia's platforms in return, Genentech said.
AI could boost the success rate of drug research and development
over the long term, Genentech said.
Genentech said it will control the sharing of its proprietary
data and Nvidia won't have direct access to them unless granted for
use in a particular project.
Write to Nina Kienle at nina.kienle@wsj.com
(END) Dow Jones Newswires
November 21, 2023 10:51 ET (15:51 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Nov 2024 to Dec 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Dec 2023 to Dec 2024
